Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Jul;31(7):730-732.
doi: 10.1038/s41431-023-01350-8. Epub 2023 Apr 10.

The absence of CFHR3 and CFHR1 genes from the T2T-CHM13 assembly can limit the molecular diagnosis of complement-related diseases

Affiliations
Comment

The absence of CFHR3 and CFHR1 genes from the T2T-CHM13 assembly can limit the molecular diagnosis of complement-related diseases

Abderaouf Hamza et al. Eur J Hum Genet. 2023 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

VF-B manages a genetic testing facility that uses MLPA in the diagnosis of aHUS. The other authors declare no competing interests.

Figures

Fig. 1
Fig. 1. Long-read sequencing and mapping against the GRCh38 reference genome reveal a structural variant in the CFHR-Factor H cluster region, allowing the precise molecular diagnosis of aHUS.
A MANE-Select transcripts [15] in the CFHR-Factor H gene cluster region in GRCh38 (top) and T2T-CMH13 (bottom). The CFHR3 and CFHR1 genes (red) are absent from T2T-CMH13. Blue and red boxes represent exons and gray lines introns. B Using GRCh38 as a reference genome, split reads mapping both to the CFH and CFHR1 loci are indicative of the presence of a structural variant responsible for the CFH::CFHR1 gene fusion, enabling the molecular diagnosis of aHUS. Control 1 and control 2 show no such alignment pattern; the absence of reads aligning on the CFHR3 and CFHR1 in control 3 suggests that this individual is a carrier of a polymorphic CFHR3-CFHR deletion [12]. Note that all three alignment patterns are easily interpretable; the aHUS patient data have been aligned with specific parameters to better visualize SV breakpoints with split reads. On this Integrative Genomics Viewer (IGV) visualization, blue lines and boxes represent gene introns and exons, respectively, and gray rectangles represent aligned reads. Thin horizontal light blue lines connecting two portions of aligned reads indicate discontinuous alignment (“split reads”).
Fig. 2
Fig. 2. The T2T-CMH13 reference genome generates aberrant patterns of alignment in the CFHR-Factor H cluster region, hindering the molecular diagnosis of aHUS.
Alignment of control 1, control 2, and the aHUS patient’s long-read sequencing data shows split reads mapped to the T2T-CMH13 CFHR-Factor H region that cannot be resolved into structural variants, obscuring any relevant variation, and making the region extremely challenging to analyze. In particular, the CFH::CFHR1 gene fusion found in the aHUS patient’s sequencing data aligned against GRCh38 (Fig. 1) is not discernible anymore. Alignment data of control 3 show no such aberrant pattern, suggesting that the subject carries the same haplotype as the CHM13hTERT cell line used to generate T2T-CMH13. On this IGV visualization, colored lines and boxes represent gene introns and exons, respectively, and gray rectangles represent aligned reads.

Comment on

  • The complete sequence of a human genome.
    Nurk S, Koren S, Rhie A, Rautiainen M, Bzikadze AV, Mikheenko A, Vollger MR, Altemose N, Uralsky L, Gershman A, Aganezov S, Hoyt SJ, Diekhans M, Logsdon GA, Alonge M, Antonarakis SE, Borchers M, Bouffard GG, Brooks SY, Caldas GV, Chen NC, Cheng H, Chin CS, Chow W, de Lima LG, Dishuck PC, Durbin R, Dvorkina T, Fiddes IT, Formenti G, Fulton RS, Fungtammasan A, Garrison E, Grady PGS, Graves-Lindsay TA, Hall IM, Hansen NF, Hartley GA, Haukness M, Howe K, Hunkapiller MW, Jain C, Jain M, Jarvis ED, Kerpedjiev P, Kirsche M, Kolmogorov M, Korlach J, Kremitzki M, Li H, Maduro VV, Marschall T, McCartney AM, McDaniel J, Miller DE, Mullikin JC, Myers EW, Olson ND, Paten B, Peluso P, Pevzner PA, Porubsky D, Potapova T, Rogaev EI, Rosenfeld JA, Salzberg SL, Schneider VA, Sedlazeck FJ, Shafin K, Shew CJ, Shumate A, Sims Y, Smit AFA, Soto DC, Sović I, Storer JM, Streets A, Sullivan BA, Thibaud-Nissen F, Torrance J, Wagner J, Walenz BP, Wenger A, Wood JMD, Xiao C, Yan SM, Young AC, Zarate S, Surti U, McCoy RC, Dennis MY, Alexandrov IA, Gerton JL, O'Neill RJ, Timp W, Zook JM, Schatz MC, Eichler EE, Miga KH, Phillippy AM. Nurk S, et al. Science. 2022 Apr;376(6588):44-53. doi: 10.1126/science.abj6987. Epub 2022 Mar 31. Science. 2022. PMID: 35357919 Free PMC article.

References

    1. Nurk S, Koren S, Rhie A, Rautiainen M, Bzikadze AV, Mikheenko A, et al. The complete sequence of a human genome. Science. 2022;376:44–53. - PMC - PubMed
    1. Aganezov S, Yan SM, Soto DC, Kirsche M, Zarate S, Avdeyev P, et al. A complete reference genome improves analysis of human genetic variation. Science. 2022;376:eabl3533. doi: 10.1126/science.abl3533. - DOI - PMC - PubMed
    1. Heinen S, Sanchez-Corral P, Jackson MS, Strain L, Goodship JA, Kemp EJ, et al. De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome. Hum Mutat. 2006;27:292–3. doi: 10.1002/humu.9408. - DOI - PubMed
    1. Detection of genetic rearrangements in the regulators of complement activation RCA cluster by high-throughput sequencing and MLPA | SpringerLink [Internet]. [cited 2021 Oct 23]. Available from: https://link.springer.com/protocol/10.1007/978-1-0716-1016-9_16. - DOI - PubMed
    1. Abarrategui-Garrido C, Martínez-Barricarte R, López-Trascasa M, de Córdoba SR, Sánchez-Corral P. Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome. Blood. 2009;114:4261–71. doi: 10.1182/blood-2009-05-223834. - DOI - PubMed

MeSH terms

LinkOut - more resources